The Prostate Health Education Network: Prostate Health Education and Awareness

Clinical Trials

A Study of Patients Receiving High-Dose Rate Brachytherapy Number: NCT00924027 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s)	Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer Number: NCT01230866 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Proton Collaborative Group Sponsor Trial Information Trial Location(s) and Contact(s)
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer Number: NCT01581749 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 4 Sponsor(s): Albert DeNittis\|Main Line Health Sponsor Trial Information Trial Location(s) and Contact(s)	Hypofractionated Proton Beam Therapy for Localized Prostate Cancer Number: NCT01950351 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): M.D. Anderson Cancer Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer Number: NCT02290366 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Ronald M. Benoit, MD\|University of Pittsburgh Sponsor Trial Information Trial Location(s) and Contact(s)	High-Dose Brachytherapy in Treating Patients With Prostate Cancer Number: NCT02346253 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1/2 Sponsor(s): Stanford University\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer Number: NCT02362451 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s)	Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer Number: NCT02454517 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Fred Hutchinson Cancer Research Center\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer Number: NCT02643667 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Washington University School of Medicine\|Pharmacyclics LLC. Sponsor Trial Information Trial Location(s) and Contact(s)	Specialized radiation therapy for Treating Patients With Prostate Cancer Number: NCT03367702 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): NRG Oncology\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
To learn more about the outcomes and early and late side effects of treating early stage prostate cancer with high dose rate brachytherapy Number: NCT03424850 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Washington University School of Medicine Sponsor Trial Information Trial Location(s) and Contact(s)	PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer Number: NCT03429244 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Indiana University Sponsor Trial Information Trial Location(s) and Contact(s)
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy Number: NCT03496805 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Wake Forest University Health Sciences Sponsor Trial Information Trial Location(s) and Contact(s)	Study of Rucaparib in Nonmetastatic Prostate Cancer Patients with Genetic Mutations Number: NCT03533946 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Utah\|Clovis Oncology, Inc. Sponsor Trial Information Trial Location(s) and Contact(s)
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment Number: NCT03572387 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Icahn School of Medicine at Mount Sinai Sponsor Trial Information Trial Location(s) and Contact(s)	Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance Number: NCT03679260 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Cedars-Sinai Medical Center Sponsor Trial Information Trial Location(s) and Contact(s)
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer Number: NCT03689582 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Michigan Rogel Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s)	Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency Number: NCT03716739 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Dana-Farber Cancer Institute\|National Institute on Aging (NIA) Sponsor Trial Information Trial Location(s) and Contact(s)
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer Number: NCT03735680 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): OncoNano Medicine, Inc. Sponsor Trial Information Trial Location(s) and Contact(s)	Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance Number: NCT03769766 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): University of Texas Southwestern Medical Center Sponsor Trial Information Trial Location(s) and Contact(s)
MRI Guided SBRT for Localized Prostate Cancer Number: NCT03778112 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Rush University Medical Center Sponsor Trial Information Trial Location(s) and Contact(s)	Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients Number: NCT03803475 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Thomas Hope\|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s)
Neoadjuvant Atezolizumab With or Without Enzalutamide in Localized Prostate Cancer Given Before Radical Prostatectomy Number: NCT03821246 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Lawrence Fong\|Genentech, Inc.\|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s)	18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer Number: NCT03824275 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2/3 Sponsor(s): Columbia University Sponsor Trial Information Trial Location(s) and Contact(s)
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer Number: NCT03860987 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s)	Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance Number: NCT03933670 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of California, San Francisco\|National Cancer Institute (NCI)\|National Institute for Biomedical Imaging and Bioengineering (NIBIB) Sponsor Trial Information Trial Location(s) and Contact(s)
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer Number: NCT04147806 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Albert Einstein College of Medicine Sponsor Trial Information Trial Location(s) and Contact(s)	HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer Number: NCT04264208 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Andrei Iagaru\|Stanford University CyberKnife Centers of San Diego Sponsor Trial Information Trial Location(s) and Contact(s)

Total: 28 Clinical Trials